Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF

Cyclophosphamide, methotrexate and fluorouracil adjuvant combination chemotherapy for breast cancer is currently used for the duration of six monthly courses. We performed a joint analysis of two studies on the duration of adjuvant cyclophosphamide, methotrexate and fluorouracil in patients with nod...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Colleoni, M, Litman, H J, Castiglione-Gertsch, M, Sauerbrei, W, Gelber, R D, Bonetti, M, Coates, A S, Schumacher, M, Bastert, G, Rudenstam, C-M, Schmoor, C, Lindtner, J, Collins, J, Thürlimann, B, Holmberg, S B, Crivellari, D, Beyerle, C, Neumann, R L A, Goldhirsch, A
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2002
Matèries:
Clinical
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375405/
https://ncbi.nlm.nih.gov/pubmed/12087454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600334
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars